Development and validation of a disease model for postmenopausal osteoporosis.

Development and validation of a disease model for postmenopausal osteoporosis.

Show other versions (2)

UNLABELLED: This article describes the development of a model for postmenopausal osteoporosis (PMO) based on Swedish data that is easily adaptable to other countries. INTRODUCTION: The aims of the study were to develop and validate a model to describe the current/future burden of PMO in different na...

Full description

Bibliographic Details
Main Authors:	Gauthier, A, Kanis, J, Martin, M, Compston, J, Borgström, F, Cooper, C, McCloskey, E
Format:	Journal article
Language:	English
Published:	2011

Similar Items

Development and validation of a disease model for postmenopausal osteoporosis.
by: Gauthier, A, et al.
Published: (2011)

DEVELOPMENT AND VALIDATION OF A DISEASE MODEL FOR POSTMENOPAUSAL OSTEOPOROSIS
by: Gauthier, A, et al.
Published: (2009)

Burden of postmenopausal osteoporosis in Germany: estimations from a disease model
by: Gauthier, A, et al.
Published: (2012)

Burden of postmenopausal osteoporosis in Germany: estimations from a disease model.
by: Gauthier, A, et al.
Published: (2012)

Epidemiological burden of postmenopausal osteoporosis in the UK from 2010 to 2021: estimations from a disease model.
by: Gauthier, A, et al.
Published: (2011)

DEVELOPMENT AND VALIDATION OF AN EPIDEMIOLOGICAL MODEL TO ESTIMATE THE BURDEN OF POST-MENOPAUSAL OSTEOPOROSIS
by: Gauthier, A, et al.
Published: (2010)

Epidemiological burden of postmenopausal osteoporosis in France from 2010 to 2020: estimations from a disease model.
by: Cawston, H, et al.
Published: (2012)

Epidemiological burden of postmenopausal osteoporosis in France from 2010 to 2020: estimations from a disease model
by: Cawston, H, et al.
Published: (2012)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
by: Kanis, J, et al.
Published: (2013)

Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).
by: Ström, O, et al.
Published: (2011)

Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013.
by: Compston, J, et al.
Published: (2013)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
by: Kanis, J, et al.
Published: (2008)

Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013 (vol 75, pg 392, 2013)
by: Compston, J, et al.
Published: (2013)

Erratum: Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013 (Maturitas (2013) 75 (392-396))
by: Compston, J, et al.
Published: (2013)

Erratum: Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013 (Maturitas (2013) 75 (392-396))
by: Compston, J, et al.
Published: (2014)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (Osteoporosis International DOI: 10.1007/s00198-008-0560-z)
by: Kanis, J, et al.
Published: (2008)

Modelling cost-effectiveness in osteoporosis
by: Kanis, J, et al.
Published: (2008)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (vol 19, pg 399, 2008)
by: Kanis, J, et al.
Published: (2008)

The cost-effectiveness of alendronate in the management of osteoporosis.
by: Kanis, J, et al.
Published: (2008)

Osteoporosis in postmenopausal women
by: Harvey, M, et al.
Published: (2002)

Pathogenesis and treatment of postmenopausal osteoporosis
by: Milhaud, G, et al.
Published: (1983)

The validity and reliability of the Malaysian osteoporosis knowledge Tool in postmenopausal women
by: Lai, P.S., et al.
Published: (2008)

Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation.
by: Delmas, P, et al.
Published: (2005)

REASONS FOR STOPPING ANTI-OSTEOPOROSIS MEDICATIONS AMONG POSTMENOPAUSAL WOMEN: THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN
by: Hooven, F, et al.
Published: (2010)

Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.
by: Rizzoli, R, et al.
Published: (2011)

Yearly zoledronic acid in postmenopausal osteoporosis.
by: Poole, K, et al.
Published: (2007)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.
by: Pazianas, M, et al.
Published: (2010)

Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).
by: Cooper, C, et al.
Published: (2012)

Baseline clinical characteristics of postmenopausal women with osteoporosis and an inadequate clinical response to osteoporosis drugs in the observational study of severe osteoporosis (OSSO).
by: Sykes, D, et al.
Published: (2005)

Natural remedies for osteoporosis in postmenopausal women.
by: Del Mar Christopher, B, et al.
Published: (2002)

Treatment of osteoporosis in men.
by: Kaufman, J, et al.
Published: (2013)

FRACTURE INCIDENCE IN OBESE POSTMENOPAUSAL WOMEN: THE GLOBAL STUDY OF OSTEOPOROSIS IN WOMEN (GLOW)
by: Compston, J, et al.
Published: (2012)

Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease.
by: Kanis, J, et al.
Published: (1997)

Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis.
by: Lips, P, et al.
Published: (1999)

Efficacy and safety of oral weekly ibandronate in the treatment of postmenopausal osteoporosis.
by: Cooper, C, et al.
Published: (2003)

The US FRAX filter: avoiding confusion or hindering progress?
by: McCloskey, E, et al.
Published: (2010)

The US FRAX® filter: avoiding confusion or hindering progress?
by: McCloskey, E, et al.
Published: (2010)

A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis.
by: Lekamwasam, S, et al.
Published: (2012)

Economic evaluation of parathyroid hormone (PTH) in the treatment of osteoporosis in postmenopausal women.
by: Lundkvist, J, et al.
Published: (2006)

Fracture risk following intermission of osteoporosis therapy
by: Dennison, EM, et al.
Published: (2019)